US 12,453,723 B2
Use of chidamide in preparing drug for treating renal fibrosis
Zhanhong Hu, Suzhou (CN); Yumei Liu, Suzhou (CN); and Liwen Mao, Suzhou (CN)
Assigned to THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY, Suzhou (CN)
Filed by THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY, Suzhou (CN)
Filed on Nov. 29, 2024, as Appl. No. 18/964,259.
Claims priority of application No. 202311681804.8 (CN), filed on Dec. 8, 2023.
Prior Publication US 2025/0108041 A1, Apr. 3, 2025
Int. Cl. A61K 31/4406 (2006.01); A61P 13/12 (2006.01)
CPC A61K 31/4406 (2013.01) [A61P 13/12 (2018.01)] 8 Claims
 
1. A method for treating renal fibrosis, comprising administering to a subject in need a pharmaceutical composition comprising a therapeutically effective dose of chidamide, wherein the chidamide is administered orally at a dose of 1-10 mg/kg/day for at least 7 days to ameliorate renal fibrosis.